论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Jia P, Wu N, Jia D, Sun Y
Received 28 January 2019
Accepted for publication 4 March 2019
Published 7 May 2019 Volume 2019:12 Pages 655—665
DOI https://doi.org/10.2147/DMSO.S203151
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 2
Editor who approved publication: Dr Juei-Tang Cheng
Purpose: The increased level of saturated fatty
acids (SFAs) is found in patients with diabetes, obesity, and other metabolic
disorders. SFAs can induce lipotoxic damage to cardiomyocytes, but the
mechanism is unclear. The long noncoding RNA metastasis-associated lung
adenocarcinoma transcript 1 (MALAT1) acts as a key regulator in palmitic acid
(PA)-induced hepatic steatosis, but its role in PA-induced myocardial lipotoxic
injury is still unknown. The aim of this study was to explore the role and
underlying mechanism of MALAT1 in PA-induced myocardial lipotoxic injury.
Methods: MALAT1
expression in PA-treated human cardiomyocytes (AC16 cells) was detected by
RT-qPCR. The effect of MALAT1 on PA-induced myocardial injury was measured by
Cell Counting Kit-8, lactate dehydrogenase (LDH), and creatine kinase-MB
(CK-MB) assays. Apoptosis was detected by flow cytometry. The activities of
cytokines and nuclear factor (NF)-κB were detected by enzyme-linked
immunosorbent assay. The interaction between MALAT1 and miR-26a was evaluated
by a luciferase reporter assay and RT-qPCR. The regulatory effects of MALAT1 on
high mobility group box 1 (HMGB1) expression were evaluated by RT-qPCR and
western blotting.
Results: MALAT1
was significantly upregulated in cardiomyocytes after PA treatment. Knockdown
of MALAT1 increased the viability of PA-treated cardiomyocytes, decreased
apoptosis, and reduced the levels of LDH, CK-MB, TNF-α, and IL-1β. Moreover, we
found that MALAT1 specifically binds to miR-26a and observed a reciprocal
negative regulatory relationship between these factors. We further found that
the downregulation of MALAT1 represses HMGB1 expression, thereby inhibiting the
activation of the Toll-like receptor 4 (TLR4)/NF-κB-mediated inflammatory
response. These repressive effects were rescued by an miR-26a inhibitor.
Conclusion: We
demonstrate that MALAT1 is induced by SFAs and its downregulation alleviates
SFA-induced myocardial inflammatory injury via the miR-26a/HMGB1/TLR4/NF-κB
axis. Our findings provide new insight into the mechanism underlying myocardial
lipotoxic injury.
Keywords: metastasis-associated
lung adenocarcinoma transcript 1, saturated fatty acids, microRNA, high
mobility group box-1 protein, inflammation
